I’ve written in the past about the use of a pharmaceutical version of the drug ketamine (known as the party drug, “Special K”) in studies with depression and with bipolar disorder. Recently, I learned researchers have published a new study looking at the impact of ketamine on obsessive compulsive disorder (OCD). I was on the … Read more
My aunt alerted me to a recent New York Times article on the use of MDMA (known as the street drug Ecstasy) to treat posttraumatic stress disorder (PTSD). I’ve written about research on the use of another drug used recreationally, ketamine, in the treatment of depression and bipolar, so I decided to check out the … Read more
The Oregonian published an Op-Ed piece that my colleague Christeine Terry and I wrote. The article addresses the growing practice of off-label use of antipsychotic medications to treat anxiety-related problems. Our aim was to bring public consciousness to this troubling trend. We write: Despite this lack of evidence, a 2007 study found nearly 1 in … Read more
There have been some articles on the National Public Radio (NPR) website about the use of the drug ketamine as a fast acting treatment for depression (See here and here). Originally developed as an anesthetic, ketamine is better known to the public as the club drug Special K. Beginning with a study published in 2006 … Read more
Here at Portland Psychotherapy, we spend a lot of time researching the most effective treatments for problems in living. Too often, though, there’s a disconnect between what the research says works and what is often used in practice. Not only is it difficult to educate the public but even mental health professionals can have difficulty … Read more
